Analystreport

Amphastar Pharmaceuticals (AMPH) had its price target lowered by Needham & Company LLC from $34.00 to $30.00. They now have a "buy" rating on the stock.

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations